Atlas Trials

Pazopanib Hydrochloride in Treating Patients With Von Hippel-Lindau Syndrome

Clinical trial NCT01436227 · COMPLETED

Trial details

NCT number
NCT01436227
Sponsor
M.D. Anderson Cancer Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Von Hippel-Lindau Syndrome
Start date
2012-01-17
Primary completion
2024-03-13
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.